AVITA Medical, Inc. RCEL
AVITA Medical, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
AVITA Medical, Inc. trades at about 7.6× earnings — below its 10-year norm (10-year range 8.7×–18.6×, median 15.8×).
Shaded band = 10-year range (8.7×–18.6×); dot = today's 7.6×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Gross margin | 82.1% | 85.8% | 84.5% | 82.4% | 79.6% | 79.2% | 76.8% |
| Operating margin | -59.4% | -88.1% | -85.1% | -79.9% | -90.8% | -299.2% | -466.4% |
| Net margin | -67.8% | -96.3% | -70.6% | -77.5% | -90.9% | -294.7% | -458.6% |
| FCF margin | -45.0% | -90.4% | -78.6% | -56.8% | -91.7% | -163.6% | -370.3% |
| Return on assets | -86.2% | -77.6% | -31.7% | -27.1% | -21.2% | -51.0% | -97.4% |
| Return on equity | 291.8% | -1374.6% | -72.1% | -31.5% | -23.0% | -58.1% | -120.5% |
| Debt / equity | -0.00× | 9.39× | 0.81× | — | — | — | — |
| Current ratio | 0.57 | 2.83 | 7.88 | 8.18 | 16.42 | 10.17 | 5.38 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.